Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-29

Clinical Trial Update: Dose-Response Study of Iocide Oral Rinse [Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 2 dose-response study of Iocide Oral Rinse for gingivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iocide Oral Rinse

Snippet

Sponsor: Biomedical Development Corporation | Conditions: Gingivitis | Phase 2 | Status: COMPLETED